Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001209191-23-032349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | 2023-05-23 | TMCI | Jain Deepti | Dir | A - Grant | $0.00 | +2,753 | 6,235 | +79% | $0 |
| D | 2023-05-25 | 2023-05-23 | TMCI | Jain Deepti | Dir | A - Grant | $0.00 | +6,305 | 6,305 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-23 | A | A | 2,753 | $0.00 | 6,235 | D | — | — | (F1) Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. (F2) Includes 3,940 RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-05-23 | A | A | 6,305 | $0.00 | 6,305 | D | $26.34 · — to 2033-05-23 | 6,305 Common Stock | (F3) The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. |